Oppenheimer lowers CorMedix stock price target to $13 on valuation
Covered in this story
What has happened since
- Cormedix Inc is up 0.0% since this was published.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
Oppenheimer’s $13 target on $CRMD is on the record and being tracked to Nov 2027 (12-month default), scored on the close that day.
Oppenheimer’s track record →Call it yourself
No member calls on $CRMD yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Cormedix Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.